check_circleStudy Completed
Renal Insufficiency, Chronic
Bayer Identifier:
21225
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Survey of patient and physician awareness and values to the diagnosis and treatment of reduced kidney function (chronic kidney disease) in patients with high blood sugar level (type 2 diabetes) (AWARE-CKD in T2D)
Trial purpose
In this survey study, researchers want to find out more about how physicians are treating patients diagnosed with reduced kidney function (chronic kidney disease, CKD) and high blood sugar level (type 2 diabetes); what physicians know about the different treatment options available; and how they use this knowledge to treat their patients successfully. Additionally, researchers want to gather information about patient's awareness of their disease and which criteria they consider important for their treatment of the disease.
The study will survey a total of 150 patients with type 2 diabetes: 50 patients with mild CKD; 50 patients with moderate CKD; and 50 patients with severe CKD. Patients eligible for this study can be male or female and should be at least 18 years old. In addition, a total of 150 physicians will be surveyed. Physicians eligible for this study may be general practitioners, endocrinologist, or nephrologists.
The study will survey a total of 150 patients with type 2 diabetes: 50 patients with mild CKD; 50 patients with moderate CKD; and 50 patients with severe CKD. Patients eligible for this study can be male or female and should be at least 18 years old. In addition, a total of 150 physicians will be surveyed. Physicians eligible for this study may be general practitioners, endocrinologist, or nephrologists.
Key Participants Requirements
Sex
AllAge
18 - N/ATrial summary
Enrollment Goal
300Trial Dates
September 2020 - April 2021Phase
N/ACould I Receive a placebo
NoProducts
UnspecifiedAccepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Recruiting | Many Facilities | Many Locations, Canada |
Primary Outcome
- Awareness of chronic kidney disease in T2DAwareness will be summarized descriptively based on various survey questions.date_rangeTime Frame:1 day
- Values regarding chronic kidney disease in T2DValues regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions.date_rangeTime Frame:1 day
- Preferences regarding chronic kidney disease in T2DPreferences regarding risks, consequences and management of chronic kidney disease will be summarized descriptively based on various survey questions.date_rangeTime Frame:1 day
Secondary Outcome
- Awareness of available treatments for chronic kidney disease in T2DAwareness of available treatments will be summarized descriptively based on various survey questions.date_rangeTime Frame:1 day
- Physician awareness of available referral tools for the management of chronic kidney disease in T2DPhysician cohort only. Referral tools may comprise of various standard guidelines (e.g. KidneyWise, KDIGO guidelines, Diabetes Canada guidelines). A higher number of referral tools known by physicians indicates a better awareness of CKD referral tools.date_rangeTime Frame:1 day
- Time point of communicated CKD diagnosisdate_rangeTime Frame:1 day
Trial design
Trial Type
ObservationalIntervention Type
OtherTrial Purpose
OtherAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A